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Abstract 
Review on lipoma with t(1;12)(p32;q14) 
HMGA2/PPAP2B, with data on clinics, and the 
genes involved. 
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Classification 
Benign lipomatous neoplasm 
Clinics and pathology 
Disease 
Ordinary lipoma 
Note 
First description of the involvement of PPAP2B in a 
chromosomal translocation 
Epidemiology 
Ordinary lipomas are the most frequent 
mesenchymal human tumors 
Clinics 
The tumor presented as a solitary mass (5.5 x 4.5 x 
2.5 cm) located in the right chest wall. 
Cytogenetics 
Cytogenetics Morphological 
The t(1;12)(p32;q14) translocation had already been 
described in lipomas (Mitelman et al., 2014) in a 
limited number of cases but had never been explored 
at the molecular level until our report (Bianchini et 
al., 2013). 
Cytogenetics Molecular 
Rearrangements of HMGA2 and PPAP2B were 
detected by metaphase FISH mapping using the 
dual-color break-apart FISH probes set RP11-30I11 
(HMGA2 5' region) and RP11-118B13 (HMGA2 3' 
region) and the dual-color break-apart FISH probes 
set RP11-485A11 (telomeric to the PPAP2B 3' UTR 
region) and RP11-20I22 (flanking the PPAP2B 5' 
UTR region) respectively. 
Genes involved and 
proteins 
HMGA2 
Location 
12q14.3 
DNA / RNA 
HMGA2 (formerly HMGI-C) is a member of the 
HMGA (high mobility group A) family. The gene is 
composed of 5 exons and spans approximately 160 
kb. Exons 3 and 4 are separated by a very large intron 
(more than 140 kb) where breakpoints have been 
reported to occur preferentially in lipoma cases 
harbouring HMGA2 rearrangements (Ashar et al., 
1995). 
Protein 
The protein is composed of 108 amino acid residues. 
It contains three DNA-binding domains (AT-hooks) 
-encoded by the three first exons- and an acidic 
carboxy-terminal region -encoded by the fifth exon- 
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which may be involved in protein-protein 
interactions.  
HMGA2 is an architectural transcription factor 
which does not have a transcription activity per se 
but contributes to transcriptional regulation by 
remodeling chromatin architecture.  
Chromosomal rearrangements involving HMGA2 
have been described in various benign tumors mostly 
of mesenchymal origin including lipomas (Ashar et 
al., 1995; Schoenmakers et al., 1995). 
PLPP3 
Location 
1p32.2 
DNA / RNA 
PPAP2B is a member of the phosphatidic acid 
phosphatase (PAP) gene family. The PPAP2B gene 
contains 6 exons and spans more than 84 kb. 
Protein 
The protein (311 amino acids and 35 kDa) encoded 
by the PPAP2B gene is LPP3 a member of the lipid 
phosphate phosphatase (LPP) family.  
LPPs are enzymes that catalyze the 
dephosphorylation of lipid phosphates including 
phosphatidate and lysophosphatidic acid. LPP3 is a 
glycoprotein containing 6 transmembrane regions 
and three catalytic domains.  
LPP3 has been reported to be involved in 
vasculogenesis (Escalante-Alcalde et al., 2003), 
neuron differentiation and neurite outgrowth 
(Sanchez-Sanchez et al., 2012).  
Only a limited number of studies have reported the 
potential involvement of LPP3 in tumorigenesis 
(Tanyi et al., 2003; Zhou et al., 2010; Chatterjee et 
al., 2011). 
Result of the chromosomal 
anomaly 
Hybrid Gene 
Description 
The t(1;12)(p32;q14) in this lipoma case results in a 
chimeric HMGA2-PPAP2B transcript fusioning 
HMGA2 3' untranslated region (UTR) with PPAP2B 
exon 6.  
The breakpoint in HMGA2 3' UTR is located 
downstream of the first let-7 microRNA binding site. 
Detection 
The chromosomal breakpoints of the 
t(1;12)(p32;q14) were first defined using a FISH-
based positional cloning strategy followed by RT-
PCR to detect potential fusion transcripts. RT-PCR 
products have been finally sequenced using 
traditional Sanger sequencing. 
Fusion Protein 
Note 
Although more than 40 chromosome bands have 
been described in rearrangements involving the 
12q13-15 region in lipomas (Bartuma et al., 2007), 
only five genes have been identified as fusion 
partners of HMGA2 before PPAP2B: LPP (3q28), 
CXCR7 (2q37),  EBF1 (5q33), LHFP (13q12) and 
NFIB (9p22) (Petit et al., 1996; Petit et al., 1999; 
Broberg et al., 2002; Nilsson et al., 2005; Nilsson et 
al., 2006; Hatano et al., 2008; Italiano et al., 2008). 
Description 
The translocation preserves the full coding region of 
HMGA2 so the HMGA2-PPAP2B fusion transcript 
is predicted to encode a full length HMGA2 protein. 
Oncogenesis 
The 3' UTR of HMGA2 contains multiple binding 
sites for the let-7 family.  Targeted mutations of 
these binding sites or functional inactivation of let-7 
result in upregulation of HMGA2 (Lee and Dutta, 
2007; Mayr et al., 2007). We  have observed that the 
t(1;12)(p32;q14) translocation results in a strong 
HMGA2 overexpression both at the mRNA and 
protein levels. Our results therefore confirm the 
hypothesis that HMGA2 overexpression can be 
induced by removal of the let-7 binding sites in 
HMGA2 3' UTR. Additional studies must be 
performed to clarify whether PPAP2B plays a role in 
the tumorigenesis of t(1;12) lipoma. 
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